GSK plans to spin off Consumer Healthcare unit
The demerger is scheduled to occur mid-next year. Before the separation, GSK is set to obtain a dividend of up to £8bn from Consumer Healthcare. With a portfolio
The demerger is scheduled to occur mid-next year. Before the separation, GSK is set to obtain a dividend of up to £8bn from Consumer Healthcare. With a portfolio
ViiV Healthcare has signed a global collaboration and license agreement with Halozyme Therapeutics to develop “ultra-long-acting” medicines for HIV. The deal gives exclusive access to Halozyme’s ENHANZE drug
The European Commission has purchased an additional 150 million Moderna’s Covid-19 vaccine doses, bringing its confirmed order commitment to 460 million doses. The deal also includes an option
Arrowhead Pharmaceuticals has signed a global collaboration and license agreement with Horizon Therapeutics for the development of RNA interference (RNAi) therapeutic, ARO-XDH. ARO-XDH is a discovery-stage investigational RNAi
Court of First Instance of Brussels has ordered AstraZeneca to deliver 50 million doses of its Covid-19 vaccine to Europe by 27 September this year. The court decided to
Established in 1998, Aldevron is headquartered in Fargo, North Dakota, US. The company produces plasmid DNA, mRNA and recombinant proteins used in vaccines, gene and cell therapy, gene editing
An investigational radioligand therapy, 177Lu-PSMA-617 is intended for precision cancer treatment. It is a combination of a targeting compound (ligand) and a therapeutic radioisotope. On administration into the
The approval is for cases where surgical intervention is a clinical indication, also known as deep partial thickness burns. StrataGraft is made of allogeneic cultured keratinocytes and dermal
TIGIT, a part of the CD226 checkpoint axis, has shown potential as a promising target for the next generation of immuno-oncology therapies based on preclinical data and a
Biotechnology company Moderna has secured approval from the European Medicines Agency’s (EMA) committee for human medicines (CHMP) for a new Covid-19 vaccine manufacturing site in Monts, France. Addition